News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication May 5, 2021 International consensus to standardise histopathological scoring for small bowel strictures in Crohn’s disease Read Now
Publication Mar 26, 2021 A Systematic Review On Immune Checkpoint Inhibitor-Associated Enterocolitis Read Now
Publication Feb 26, 2021 Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn’s Disease After Elective Surgery: Meta-Analysis Read Now
Publication Feb 19, 2021 Vedolizumab for the Treatment of Noninflammatory Bowel Disease Related Enteropathy Read Now
Publication Dec 18, 2020 Early Combined Immunosuppression Reduces Complications in Long-standing Crohn’s Disease: A Post Hoc Analysis of REACT Read Now
Publication Dec 15, 2020 Endoscopic Assessment of Inflammatory Bowel Disease Activity in Clinical Trials Read Now
